Ocata Therapeutics, Inc.: 10-Q filed 2011-11-08
What Ocata Therapeutics, Inc. reported in its quarterly report filed 2011-11-08 (fiscal Q3 2011): 34 published measures, 96 facts as tagged in accession 0001144204-11-062107.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2011-11-08
- Fiscal period
- fiscal Q3 2011
- Accession
- 0001144204-11-062107 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Ocata Therapeutics, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 16,285,602 | USD | |
| At 2010-12-31 | 19,054,152 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 61,167,317 | USD | |
| At 2010-12-31 | 41,434,801 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | -46,270,599 | USD | |
| At 2010-12-31 | -23,653,090 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 13,902,121 | USD | |
| At 2010-12-31 | 15,889,409 | USD | |
| At 2010-09-30 | 2,195,118 | USD | |
| At 2009-12-31 | 2,538,838 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | -52,521,029 | USD | 92 |
| 2011-01-01 to 2011-09-30 | -60,683,215 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 1,935,715 | USD | 92 |
| 2010-01-01 to 2010-09-30 | -12,983,519 | USD | 273 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | -10,828,173 | USD | 273 |
| 2010-01-01 to 2010-09-30 | -7,298,540 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | 36,830 | USD | 273 |
| 2010-01-01 to 2010-09-30 | 186,449 | USD | 273 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 132,805 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 440,181 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 205,158 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 615,474 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | 8,877,715 | USD | 273 |
| 2010-01-01 to 2010-09-30 | 7,153,865 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | -36,830 | USD | 273 |
| 2010-01-01 to 2010-09-30 | -199,045 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | -241,697,329 | USD | |
| At 2010-12-31 | -180,949,523 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 1,613,530,283 | shares | 92 |
| 2011-01-01 to 2011-09-30 | 1,546,379,685 | shares | 273 |
| 2010-07-01 to 2010-09-30 | 969,174,877 | shares | 92 |
| 2010-01-01 to 2010-09-30 | 756,009,975 | shares | 273 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 1,613,530,283 | shares | 92 |
| 2011-01-01 to 2011-09-30 | 1,546,379,685 | shares | 273 |
| 2010-07-01 to 2010-09-30 | 969,759,448 | shares | 92 |
| 2010-01-01 to 2010-09-30 | 756,009,975 | shares | 273 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | -0.03 | USD/shares | 92 |
| 2011-01-01 to 2011-09-30 | -0.04 | USD/shares | 273 |
| 2010-07-01 to 2010-09-30 | 0 | USD/shares | 92 |
| 2010-01-01 to 2010-09-30 | -0.02 | USD/shares | 273 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | -0.03 | USD/shares | 92 |
| 2011-01-01 to 2011-09-30 | -0.04 | USD/shares | 273 |
| 2010-07-01 to 2010-09-30 | 0 | USD/shares | 92 |
| 2010-01-01 to 2010-09-30 | -0.02 | USD/shares | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 167,983 | USD | |
| At 2010-12-31 | 185,102 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | 2,831,250 | USD | 273 |
| 2010-01-01 to 2010-09-30 | 782,473 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | -6,895,786 | USD | 92 |
| 2011-01-01 to 2011-09-30 | -15,343,252 | USD | 273 |
| 2010-07-01 to 2010-09-30 | -5,406,563 | USD | 92 |
| 2010-01-01 to 2010-09-30 | -21,506,765 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 14,275,045 | USD | |
| At 2010-12-31 | 15,981,007 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 48,794,348 | USD | |
| At 2010-12-31 | 11,343,120 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 1,630,383 | USD | |
| At 2010-12-31 | 1,982,743 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 24,950 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 7,011,941 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 15,462,383 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 5,545,071 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 21,922,289 | USD | 273 |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 116,155 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 119,131 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 138,508 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 415,524 | USD | 273 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 16,650 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 321,050 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 66,650 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 199,950 | USD | 273 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 4,035,722 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 7,042,766 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 1,348,503 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 6,728,225 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 1,647,644,900 | shares | |
| At 2010-12-31 | 1,439,826,362 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 214,688,527 | USD | |
| At 2010-12-31 | 166,033,976 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 1,789,503 | USD | |
| At 2010-12-31 | 4,971,304 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | -52,521,029 | USD | 92 |
| 2011-01-01 to 2011-09-30 | -60,683,215 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 1,935,715 | USD | 92 |
| 2010-01-01 to 2010-09-30 | -12,983,519 | USD | 273 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 2,976,219 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 8,125,473 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 1,094,604 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 13,662,066 | USD | 273 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | 53,949 | USD | 273 |
| 2010-01-01 to 2010-09-30 | 94,867 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | -45,625,243 | USD | 92 |
| 2011-01-01 to 2011-09-30 | -45,339,963 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 7,342,278 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 8,523,246 | USD | 273 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | 24,950 | USD | 273 |
Inspect the source
- Entity
- Ocata Therapeutics, Inc. / CIK 0001140098
- Captured
- SEC response SHA-256
35ed5f9b7b65d6962e417af6d880d4a32b17c4db50d76618066bbdf10dcb4c40
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001140098.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))